In Vivo delivery of CRISPR-Cas9 ribonucleoprotein complex to the retina via a cell penetrating peptide

被引：0
|
作者：
Yanez, Vanessa [1 ]
Kumar-Singh, Rajendra [1 ]
机构：
[1] Tufts Univ, Boston, MA 02111 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1707
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
    Padilla, Marshall S.
    Mrksich, Kaitlin
    Wang, Yiming
    Haley, Rebecca M.
    Li, Jacqueline J.
    Han, Emily L.
    El-Mayta, Rakan
    Kim, Emily H.
    Dias, Sofia
    Gong, Ningqiang
    Teerdhala, Sridatta V.
    Han, Xuexiang
    Chowdhary, Vivek
    Xue, Lulu
    Siddiqui, Zain
    Yamagata, Hannah M.
    Kim, Dongyoon
    Yoon, Il-Chul
    Wilson, James M.
    Radhakrishnan, Ravi
    Mitchell, Michael J.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [42] Spatial control of in vivo CRISPR-Cas9 genome editing via nanomagnets
    Zhu, Haibao
    Zhang, Linlin
    Tong, Sheng
    Lee, Ciaran M.
    Deshmukh, Harshavardhan
    Bao, Gang
    NATURE BIOMEDICAL ENGINEERING, 2019, 3 (02) : 126 - 136
  • [43] Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles
    Nielsen, Ian Helstrup
    Rovsing, Anne Bruun
    Janns, Jacob Horluck
    Thomsen, Emil Aagaard
    Ruzo, Albert
    Boggild, Andreas
    Nedergaard, Frederikke
    Moller, Charlotte Thornild
    Boesen, Thomas
    Degn, Soren Egedal
    V. Shah, Jagesh
    Mikkelsen, Jacob Giehm
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (04):
  • [44] Nanoblades: Pseudoviral shuttles for CRISPR-CAS9 delivery
    Mangeot, Philippe E.
    VIROLOGIE, 2019, 23 (01) : 3 - 6
  • [45] In vivo gene therapy potentials of CRISPR-Cas9
    Xue, H-Y
    Zhang, X.
    Wang, Y.
    Xiaojie, L.
    Dai, W-J
    Xu, Y.
    GENE THERAPY, 2016, 23 (07) : 557 - 559
  • [46] In vivo gene therapy potentials of CRISPR-Cas9
    H-Y Xue
    X Zhang
    Y Wang
    L Xiaojie
    W-J Dai
    Y Xu
    Gene Therapy, 2016, 23 : 557 - 559
  • [47] Inducible in vivo genome editing with CRISPR-Cas9
    Lukas E Dow
    Jonathan Fisher
    Kevin P O'Rourke
    Ashlesha Muley
    Edward R Kastenhuber
    Geulah Livshits
    Darjus F Tschaharganeh
    Nicholas D Socci
    Scott W Lowe
    Nature Biotechnology, 2015, 33 : 390 - 394
  • [48] Inducible in vivo genome editing with CRISPR-Cas9
    Dow, Lukas E.
    Fisher, Jonathan
    O'Rourke, Kevin P.
    Muley, Ashlesha
    Kastenhuber, Edward R.
    Livshits, Geulah
    Tschaharganeh, Darjus F.
    Socci, Nicholas D.
    Lowe, Scott W.
    NATURE BIOTECHNOLOGY, 2015, 33 (04) : 390 - U98
  • [49] Cell penetrating peptide-mediated nuclear delivery of Cas9 to enhance the utility of CRISPR/Cas genome editing
    Axford, David S.
    Morris, Daniel P.
    McMurry, Jonathan L.
    FASEB JOURNAL, 2017, 31
  • [50] In vivo gene editing in mice through systemic delivery of CRISPR/Cas9-ribonucleoprotein
    Lee, Yi-Wei
    Luther, David
    Liu, Yuanchang
    Castellanos, Laura
    Hardie, Joseph
    Vachet, Richard
    Rotello, Vincent
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
12345